Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V7VF
|
||||
Former ID |
DNC009398
|
||||
Drug Name |
N-(3-(3-methoxyphenyl)-3-phenylallyl)acetamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C18H19NO2
|
||||
Canonical SMILES |
CC(=O)NCC=C(C1=CC=CC=C1)C2=CC(=CC=C2)OC
|
||||
InChI |
1S/C18H19NO2/c1-14(20)19-12-11-18(15-7-4-3-5-8-15)16-9-6-10-17(13-16)21-2/h3-11,13H,12H2,1-2H3,(H,19,20)/b18-11+
|
||||
InChIKey |
SJNURYXTMIYOKB-WOJGMQOQSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Melatonin receptor | Target Info | Inhibitor | [1] | |
Melatonin receptor type 1B | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Circadian entrainmenthsa04080:Neuroactive ligand-receptor interaction | |||||
Circadian entrainment | |||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors) | |||||
G alpha (i) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Small Ligand GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | J Med Chem. 2009 Feb 12;52(3):826-33.2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.